Pharma Mar, S.A. PHMMF
94.60 USD +17.51 +22.71%
At close · Oct 30
77.09 52-week range 106.48
- YTD
- +9.67%
- 1 year
- +1.72%
- Open
- 94.60
- Prev close
- 77.09
- Mkt cap
- 1.63B
- Vol
- 100
- Avg vol
- 17
- EPS
- 4.32
- P/E
- 21.90
More statistics
- Low
- 94.60
- High
- 94.60
- Earnings
- Oct 29, 2026
MAX chart
Chart tools
Chart is warming up
The all-time price history for PHMMF has not been loaded yet. Try again in a moment.
Altman Z-Score
8.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 3
- P/E 3
- P/B 2
P/E 17.1×
P/S 5.7×
P/B 5.0×
P/FCF 28.9×
EV/EBITDA 26.8×
EV/Sales 5.9×
FCF Yield 3.5%
Gross Margin 94.5%
Operating Margin 18.2%
Net Margin 33.9%
ROE 29.8%
ROIC 12.8%
ROA 19.0%
Revenue 26.6%
Operating Income 522.5%
EPS (diluted) 188.6%
Free Cash Flow 561.2%
Current Ratio 3.0×
Quick Ratio 2.4×
Debt / Equity 0.2×
Net Debt / EBITDA 0.7×
Interest Coverage 16.4×
Dividend Yield 1.1%
Payout Ratio 18.6%
Annual · latest fiscal year ends 2025-12-31